PrescriptionDrugs.org

What to Expect When Starting Rivaroxaban

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Rivaroxaban (brand name Xarelto) is a direct oral anticoagulant (DOAC) that works by selectively inhibiting factor Xa, a key enzyme in the blood coagulation cascade [1]. It is prescribed for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke prevention in atrial fibrillation, and reduction of cardiovascular risk [1]. Unlike warfarin, rivaroxaban does not require routine INR monitoring and has fewer drug and food interactions, making it more convenient for most patients.

Week-by-week timeline

Day 1-7Minor bleeding events (bruising, gum bleeding, nosebleeds) are common initially as your body adjusts to anticoagulation.

Immediate Anticoagulation

Rivaroxaban reaches therapeutic anticoagulant levels within 2-4 hours of the first dose [1]. For DVT/PE treatment, you will typically start at 15 mg twice daily with food for the first 21 days. For atrial fibrillation, the standard dose is 20 mg once daily with the evening meal. Taking it with food increases bioavailability by 39% and is critical for proper absorption [2]. You are protected from new clot formation almost immediately, but existing clots take weeks to months for the body to resolve.

Week 1-3These effects reflect the medication working as intended. Learn to recognize the difference between expected minor bleeding and signs of serious hemorrhage.

Adjusting to Anticoagulation

Your body adapts to being anticoagulated. You may notice that cuts take longer to stop bleeding, bruises appear more easily, and minor injuries produce more bleeding than before [1]. For DVT/PE patients, leg swelling and pain should gradually improve as the clot stabilizes and begins to resolve. Headache, dizziness, and mild GI symptoms (nausea, abdominal discomfort) are reported in clinical trials but are generally mild [2].

Week 3-8The dose transition is straightforward but confirm the timing and new regimen with your pharmacist to avoid confusion.

Dose Transition and Stabilization

For DVT/PE treatment, you transition from 15 mg twice daily to 20 mg once daily with food after 21 days [1]. This marks the shift from acute treatment to ongoing prevention. Most patients feel largely back to normal by this stage. For atrial fibrillation patients, no dose change occurs — the 20 mg daily regimen continues. Your doctor may check renal function (rivaroxaban is partially renally cleared) and hemoglobin to ensure no occult bleeding [2].

Month 3-6Long-term rivaroxaban is well tolerated. Do not stop without medical guidance, as abrupt discontinuation increases thrombotic risk.

Long-Term Maintenance

Rivaroxaban becomes a routine part of daily life. The ROCKET AF trial demonstrated non-inferiority to warfarin for stroke prevention in atrial fibrillation, with significantly less intracranial hemorrhage [3]. For DVT/PE, your doctor will assess whether to continue beyond 3-6 months based on whether the clot was provoked or unprovoked. Consistent daily dosing with food is the most important factor for maintaining reliable anticoagulation [1].

When to call your doctor

Contact your healthcare provider if you experience:

  • Any signs of serious bleeding: blood in urine (pink or brown), blood in stool (black/tarry or bright red), coughing up blood, vomiting blood or material that looks like coffee grounds [1]
  • Unusual or prolonged bleeding from cuts, gums, or nose that does not stop with pressure [1]
  • Sudden severe headache, confusion, vision changes, or weakness on one side of the body — may indicate intracranial hemorrhage [1]
  • Excessive bruising without known cause, or significant swelling at an injury site [2]
  • Signs of a new blood clot despite treatment: sudden leg swelling, chest pain, or shortness of breath [1]

Tips for getting started

Always take rivaroxaban with food — the evening meal is recommended for the 20 mg dose to maximize absorption [1]. Set a daily alarm if needed, as consistent timing is important since there is no routine blood monitoring to detect missed doses. Inform all healthcare providers (including dentists) that you are on an anticoagulant before any procedures. Wear a medical alert bracelet or carry a card indicating you take rivaroxaban. Avoid activities with high risk of traumatic injury, and use an electric razor and soft toothbrush to minimize minor bleeding [2].

Frequently asked questions

More about Rivaroxaban

References

  1. [Regulatory] Xarelto (rivaroxaban) FDA Prescribing Information. Janssen Pharmaceuticals. Revised 2024. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022406s043lbl.pdf Accessed 2025-01-15.
  2. [Regulatory] Rivaroxaban. StatPearls [Internet]. National Library of Medicine. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK557883/ Accessed 2025-01-15.
  3. [Clinical] Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF). N Engl J Med. 2011;365(10):883-891. https://pubmed.ncbi.nlm.nih.gov/21830957/ Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: